Niacin receptor agonists, compositions containing such compounds and methods of treatment

Details for Australian Patent Application No. 2006331731 (hide)

Owner Merck & Co., Inc.

Inventors Imbriglio, Jason; Raghavan, Subharekha; Ding, Fa-Xiang; Schmidt, Darby Rye; Colletti, Steven L.; Marley, Daria; Chen, Weichun; Bodner, Rena; Lins, Ashley Rouse; Shen, Hong; Beresis, Richard T.; Tata, James R.; Smenton, Abigail L.

Agent Spruson & Ferguson

Pub. Number AU-A-2006331731

PCT Pub. Number WO2007/075749

Priority 60/751,877 20.12.05 US

Filing date 20 December 2006

Wipo publication date 5 July 2007

International Classifications

C07D 417/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/075749 Priority application(s): WO2007/075749

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331733-Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression

2006331729-UV-radiation protectant compositions